D. Stroncek

3.2k citations
12 papers · 2.4k · 1 hit paper · h-index 5

Impact in

  • Oncology top 1%
    • CAR-T cell therapy research
  • Immunology top 5%
    • Immune Cell Function and Interaction
    • Immunotherapy and Immune Responses

Papers in

    • CAR-T cell therapy research 6
    • Immunotherapy and Immune Responses 2
    • Immune Cell Function and Interaction 2

D. Stroncek

11 papers receiving 2.3k citations

D. Stroncek's Hit Papers

T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial 2014 · 2.2k citations
2.2k0+4+8Years since publication50010001.5k2.0k

Peers

D. Stroncek
Comparison fields: 5 of 62
  • Oncology 2.1k
  • Immunology 596
  • Genetics 573
  • Hematology 167
  • Biomedical Engineering 484
Replace Rebecca Gardner with:
Rebecca Gardner United States
Elena Mead United States
Catherine Lindgren United States
Cindy Delbrook United States
Haruko Tashiro Japan
Barbara Camisa Italy
Antonio Di Stasi United States
Sherry Adkins United States
Jonathan D. Fish United States
D. Stroncek relative to Rebecca Gardner United States Rebecca Gardner's profile →
Citations per field
00.5×4.1×
Rebecca Gardner · 1×
Citations per year

Countries citing papers authored by D. Stroncek

Since Specialization
Citations

This map shows the geographic impact of D. Stroncek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Stroncek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Stroncek more than expected).

Fields of papers citing papers by D. Stroncek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Stroncek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Stroncek. The network helps show where D. Stroncek may publish in the future.

Co-authors

The 25 scholars most cited alongside D. Stroncek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with D. Stroncek Line = papers co-authored together D. Stroncek links everyone, so they are left out of the graph.

All Works

12 of 12 papers shown
#Work
1
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
Hit paper breakdown →
20142181
2 201689
3 201143
4
Nucleic acid amplification testing of blood donors for transfusion-transmitted infectious diseases
200035
5 20028
6 20092
7 20042
8 20132
9 20002
10 20131
11 20201
12 20150

About D. Stroncek

D. Stroncek is a scholar working on Oncology, Immunology, Epidemiology, Hematology and Surgery, having authored 12 papers that have together received 2.4k indexed citations. Recurring topics across this work include CAR-T cell therapy research (6 papers), Immunotherapy and Immune Responses (2 papers), Immune Cell Function and Interaction (2 papers), Sarcoma Diagnosis and Treatment (1 paper), Organ Transplantation Techniques and Outcomes (1 paper), Viral Infectious Diseases and Gene Expression in Insects (1 paper), Acute Lymphoblastic Leukemia research (1 paper) and Hepatitis B Virus Studies (1 paper). The work is most often cited by research in Oncology (2.1k citations), Immunology (596 citations), Genetics (573 citations), Hematology (167 citations) and Biomedical Engineering (484 citations). D. Stroncek has collaborated with scholars based in United States, Japan and India. Frequent co-authors include Marianna Sabatino, Seth M. Steinberg, Yongzhi Cui, Crystal L. Mackall, Alan S. Wayne, Ling Zhang, Daniel W Lee, Nirali N. Shah, Rimas J. Orentas and Steven A. Feldman. Their work appears in journals such as Journal of Clinical Oncology, Journal of Immunotherapy, Clinical Cancer Research, The Lancet and Cytotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact